<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 22 Feb 2022 07:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Receipt+of+Comments+from+Australian+Ethics+Committee+Regarding+the+Company%E2%80%99s+Phase+1+Clinical+Study+of+R-107+and+Closing+of+Financing/19652326.html</guid>
   <pubDate>Tue, 22 Feb 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Anticipates+Response+from+Australian+Ethics+Committee+by+February+18%2C+2022/19579962.html</guid>
   <pubDate>Wed, 09 Feb 2022 07:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Revised%2C+Improved+Terms+for+Initial+Tranche+of+Financing+with+Alumina+Partners/19510701.html</guid>
   <pubDate>Wed, 26 Jan 2022 17:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</guid>
   <pubDate>Mon, 17 Jan 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</guid>
   <pubDate>Mon, 17 Jan 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns</title>
   <link>http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</guid>
   <pubDate>Mon, 17 Jan 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</guid>
   <pubDate>Mon, 17 Jan 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
  <item>
   <title>Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Claritas+Announces+Letter+of+Intent+to+Acquire+Worldwide+Rights+to+R-107+for+Treatment+of+Wound+Healing%2C+Skin+Ulcers+and+Severe+Burns/19465814.html</guid>
   <pubDate>Mon, 17 Jan 2022 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">KALTF</category>
   	  </item>
 </channel>
</rss>
